{
  "docId": "019dd923-5eff-723e-9be8-8ecf5ec778da",
  "docSlug": "2EobkBpnCoKZCisTIQTA",
  "documentTitle": "Here's the 13-slide pitch deck ReCode Therapeutics used to raise $120 million from OrbiMed and Pfizer to develop new mRNA medicines",
  "authorId": "Pitchdecks",
  "authorName": "ReCode Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.774,
  "pageNumber": 6,
  "pageCount": 13,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses authority-citation to establish scientific credibility for the company's core technology.",
  "elementsJson": [
    "action_title",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5eff-723e-9be8-8ecf5ec778da/6",
  "deckHref": "/decks/019dd923-5eff-723e-9be8-8ecf5ec778da",
  "deckJsonHref": "/decks/019dd923-5eff-723e-9be8-8ecf5ec778da.json",
  "deckAnchorHref": "/decks/019dd923-5eff-723e-9be8-8ecf5ec778da#slide-6",
  "components": [
    {
      "bbox": null,
      "kind": "framework",
      "text": "Citing peer-reviewed journals to validate technology",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57a18d98-bb08-471a-aed3-1d35ca341c33",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.2
      },
      "kind": "image",
      "text": "Nature Communications article snippet",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0424774d-ee25-4ea3-9ddd-8324eef879c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "image",
      "text": "Nature Nanotechnology article snippet",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fa30e4d-4762-49c7-bcae-2485287587dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "image",
      "text": "PNAS article snippet",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "924c1480-9013-4157-adc5-88c39e6fa087",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.58
      },
      "kind": "image",
      "text": "Nature Technology Feature snippet",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1770877-c554-459d-9c3e-8b9f72321214",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Lipid nanoparticles provide a non-viral alternative, and several studies published over the past few years highlight the potential to tune their specificity. For example, the selective organ targeting (SORT) approach... enables the rapid generation and screening of lipid nanoparticles to identify those that can effectively target cells in tissues such as the lung or spleen.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-9437-76cb-b83b-35531cb07f52",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "SORT platform was the first to demonstrate extra-hepatic tissue delivery of lipid nanoparticles",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9905f38-0d02-4f81-85af-1d1b8eaddea0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Authority citation",
      "slug": "authority-citation",
      "agent": null,
      "layer": "slide",
      "matchId": "cd84a755-5e02-48e5-a6d5-2bb811bbe785",
      "evidence": "framework/instance: Citing peer-reviewed journals to validate technology",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "79743605-50f3-4e8d-b3b4-b68ffa262c0d",
      "evidence": "Use of high-impact scientific journal headers to establish credibility.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "778dc6ec-3fb1-45db-b6f4-9edc29c9aa32",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 6-10: SORT platform capabilities and advantages",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 9,
      "from": 6,
      "beatId": "3d1c65e6-04be-45d8-b316-6c794e15a0d6",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Slides 6-9: SORT platform achievements and data",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}